Epelsiban

CAS: 872599-83-2

Ref. 3D-XJB59983

Informação sobre produto

• Nome: Epelsiban
• Sinónimos: Morpholine, 4-[(2R)-[(3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-6-[(1S)-1-methylpropyl]-2,5-dioxo-1-piperazinyl](2,6-dimethyl-3-pyridinyl)acetyl]-, (3R,6R)-3-(2,3-Dihydro-1H-inden-2-yl)-1-[(1R)-1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-2,5-piperazinedione, GSK 557296, 2,5-Piperazinedione, 3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-, (3R,6R)-

Descrição

Epelsiban is a drug that belongs to the class of oxime derivatives. It is used as a modulator and has been shown to have specific treatment effects in animal studies. Epelsiban is also an enantioselective method which targets the oxytocin receptor and has been shown to have single-dose pharmacokinetics. Epelsiban has been shown to be safe in animals, although it can cause adverse reactions such as drug reactions, nausea, vomiting and diarrhea. Epelsiban may also cause endometrial hyperplasia and uterine cancer in women.

• Marca: Biosynth

Propriedades químicas

• Peso molecular: 518.6 g/mol
• Fórmula: C₃₀H₃₈N₄O₄
• Pureza: Min. 95%